Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PARNAX LAB vs BAL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PARNAX LAB BAL PHARMA PARNAX LAB/
BAL PHARMA
 
P/E (TTM) x 15.9 27.8 57.3% View Chart
P/BV x 2.6 3.1 85.4% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 PARNAX LAB   BAL PHARMA
EQUITY SHARE DATA
    PARNAX LAB
Mar-24
BAL PHARMA
Mar-24
PARNAX LAB/
BAL PHARMA
5-Yr Chart
Click to enlarge
High Rs142132 107.2%   
Low Rs5267 77.4%   
Sales per share (Unadj.) Rs164.2214.7 76.5%  
Earnings per share (Unadj.) Rs8.44.7 177.8%  
Cash flow per share (Unadj.) Rs14.411.1 130.2%  
Dividends per share (Unadj.) Rs01.20 0.0%  
Avg Dividend yield %01.2 0.0%  
Book value per share (Unadj.) Rs62.343.9 142.0%  
Shares outstanding (eoy) m11.4915.80 72.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.60.5 126.9%   
Avg P/E ratio x11.621.2 54.6%  
P/CF ratio (eoy) x6.79.0 74.6%  
Price / Book Value ratio x1.62.3 68.4%  
Dividend payout %025.5 0.0%   
Avg Mkt Cap Rs m1,1141,578 70.6%   
No. of employees `000NANA-   
Total wages/salary Rs m237604 39.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,8873,392 55.6%  
Other income Rs m828 28.7%   
Total revenues Rs m1,8953,421 55.4%   
Gross profit Rs m235317 74.2%  
Depreciation Rs m70101 69.1%   
Interest Rs m53154 34.6%   
Profit before tax Rs m12190 133.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2416 151.4%   
Profit after tax Rs m9674 129.3%  
Gross profit margin %12.59.3 133.5%  
Effective tax rate %20.117.7 113.7%   
Net profit margin %5.12.2 232.4%  
BALANCE SHEET DATA
Current assets Rs m7182,341 30.7%   
Current liabilities Rs m8182,030 40.3%   
Net working cap to sales %-5.39.2 -57.9%  
Current ratio x0.91.2 76.1%  
Inventory Days Days613 46.8%  
Debtors Days Days6301,072 58.7%  
Net fixed assets Rs m1,133830 136.6%   
Share capital Rs m115158 72.7%   
"Free" reserves Rs m601535 112.3%   
Net worth Rs m716693 103.3%   
Long term debt Rs m211363 57.9%   
Total assets Rs m1,8883,171 59.5%  
Interest coverage x3.31.6 205.2%   
Debt to equity ratio x0.30.5 56.1%  
Sales to assets ratio x1.01.1 93.5%   
Return on assets %7.97.2 109.9%  
Return on equity %13.410.7 125.2%  
Return on capital %18.823.2 81.0%  
Exports to sales %3.657.5 6.2%   
Imports to sales %018.8 0.0%   
Exports (fob) Rs m681,950 3.5%   
Imports (cif) Rs mNA638 0.0%   
Fx inflow Rs m681,950 3.5%   
Fx outflow Rs m0691 0.0%   
Net fx Rs m681,259 5.4%   
CASH FLOW
From Operations Rs m159228 69.6%  
From Investments Rs m-315-189 166.8%  
From Financial Activity Rs m148-12 -1,228.6%  
Net Cashflow Rs m-827 -30.3%  

Share Holding

Indian Promoters % 72.3 46.7 154.7%  
Foreign collaborators % 0.0 4.1 -  
Indian inst/Mut Fund % 0.0 0.1 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 27.7 49.1 56.4%  
Shareholders   4,173 16,007 26.1%  
Pledged promoter(s) holding % 9.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PARNAX LAB With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on PARNAX LAB vs BAL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PARNAX LAB vs BAL PHARMA Share Price Performance

Period PARNAX LAB BAL PHARMA S&P BSE HEALTHCARE
1-Day 10.38% -2.08% 0.74%
1-Month 11.73% 10.20% -0.72%
1-Year 88.49% 24.25% 42.93%
3-Year CAGR 79.55% 12.89% 20.16%
5-Year CAGR 55.61% 26.73% 26.12%

* Compound Annual Growth Rate

Here are more details on the PARNAX LAB share price and the BAL PHARMA share price.

Moving on to shareholding structures...

The promoters of PARNAX LAB hold a 72.3% stake in the company. In case of BAL PHARMA the stake stands at 50.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PARNAX LAB and the shareholding pattern of BAL PHARMA.

Finally, a word on dividends...

In the most recent financial year, PARNAX LAB paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BAL PHARMA paid Rs 1.2, and its dividend payout ratio stood at 25.5%.

You may visit here to review the dividend history of PARNAX LAB, and the dividend history of BAL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.